Showing results (11-20 of 161) with videos related to
Sort By:
Pageof 17
Critical Reviews in Oncology/Hematology|July 11, 2006
Novel targets in gastric and esophageal cancerClaudia María Valverde, Teresa Macarulla, Esther Casado, et al.Therapeutic Advances in Medical Oncology|January 17, 2013
Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?Teresa Troiani, Erika Martinelli, Floriana Morgillo, et al.Molecular Cancer Therapeutics|June 21, 2008
Sequence-dependent, synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin, a protein kinase Cbeta inhibitor, in non-small cell lung cancer cellsFloriana Morgillo, Erika Martinelli, Teresa Troiani, et al.The Lancet. Gastroenterology & Hepatology|May 2, 2024
Targeting the EGFR signalling pathway in metastatic colorectal cancerStefania Napolitano, Giulia Martini, Davide Ciardiello, et al.Cancer Treatment Reviews|May 13, 2019
Immunotherapy of colorectal cancer: Challenges for therapeutic efficacyDavide Ciardiello, Pietro Paolo Vitiello, Claudia Cardone, et al.Expert Opinion on Emerging Drugs|December 11, 2012
Emerging VEGF-receptor inhibitors for colorectal cancerErika Martinelli, Teresa Troiani, Floriana Morgillo, et al.Journal of Oncology|January 10, 2023
Hepatocellular Carcinoma: Current Therapeutic Algorithm for Localized and Advanced DiseaseAnju Jose, Maria Grazia Bavetta, Erika Martinelli, et al.Expert Opinion on Biological Therapy|January 4, 2013
Optimizing treatment of metastatic colorectal cancer patients with anti-EGFR antibodies: overcoming the mechanisms of cancer cell resistanceTeresa Troiani, Silvia Zappavigna, Erika Martinelli, et al.International Journal of Environmental Research and Public Health|March 20, 2020
An Anecdotal Case Report of Chronic Lymphatic Leukemia with del(11q) Treated with Ibrutinib: Artificial Nourishment and Physical Activity ProgramAntonello Sica, Caterina Sagnelli, Alfonso Papa, et al.ESMO Open|November 16, 2016
Therapeutic value of EGFR inhibition in CRC and NSCLC: 15 years of clinical evidenceTeresa Troiani, Stefania Napolitano, Carminia Maria Della Corte, et al.Pageof 17